GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jul 1, 2014

In Genetic Haystacks, We’re All Needles

According to Sharon Terry, as we scrutinize diseases at an ever more granular level, we will find that whatever disease a person has, it’s highly likely to be a “rare” disease.

In Genetic Haystacks, We’re All Needles

Sharon Terry is president and CEO of Genetic Alliance.

  • The task of finding and recruiting sufficiently large cohorts for studying genetic diseases has up to now been a needle in the haystack problem. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?